LP-001-09

N/A

Report date: 2023/02/18 19:46:35
NME

Base Information

Drug NameLP-001-09
Drug Alias NameLPD-1050LP-001-09LP-00109
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionImmunosuppressantsHIV integrase inhibitorsAngiogenesis inhibitors
TargetsHIV integrase
Therapy Area/IndicationsPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesLaila Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLaila Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsPsoriasis

Other Information

ATC CodeN/A
Related LinksN/A